Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03227432. IPD Sharing: NO. Countries: 1. Publications: 0.
a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT04008888. IPD Sharing: NO. Countries: 1. Publications: 0.
RMPT for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00961467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05850234. IPD Sharing: YES. Countries: 1. Publications: 0.
The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04762745. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04182581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03605719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01301807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-Fluciclovine PET/CT in Multiple Myeloma
ClinicalTrials.gov study NCT06103838. IPD Sharing: YES. Countries: 1. Publications: 0.
CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma
ClinicalTrials.gov study NCT04727008. IPD Sharing: NO. Countries: 1. Publications: 0.
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06348108. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT00511082. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00996957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03475628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04975399. IPD Sharing: YES. Countries: 3. Publications: 0.
Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting
ClinicalTrials.gov study NCT05041933. IPD Sharing: NO. Countries: 1. Publications: 0.
Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Tri
ClinicalTrials.gov study NCT04024384. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
ClinicalTrials.gov study NCT03524235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT02504359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00004903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.